Replies to post #8399 on DNAprint Genomics (DNAG)

[bag8ger]

Mingwan0,

Interesting that Paula S Fuqua is/was with University of florida.

Someone that knowledgable about FDA procedures should be able to recognize contribution DNAP coud make to approval process.

And to be in Florida, it might help.

I'm trying to locate an email for her.

[chig]

Mingwan....

That was August, 1998, a couple years before DNAP. Towards the end:

"Additional change can also be expected as genomics, the study of the genetic basis for disease, comes to the forefront of drug discovery. Genomics has created a whole new field of research in which drugs will be designed with specific biological targets in mind. As a result, manufacturers are increasing their new drug discovery goals at an astonishing rate, depending on genomics in combination with computer simulations to allow better design of clinical trials.14

The future is bright, indeed. If these new changes within the FDA and at the manufacturer and investigator levels can work in concert, the United States will have an efficient, proactive, and dynamic drug approval process. This process can be finely tuned to meet the needs of the agent it must evaluate and carefully honed to assure that adequate safety and efficacy of a potential new medication have been demonstrated prior to marketing for general public consumption."

Now, how does the FDA do it's job when everyone knows more about the science than they do? The key is to not let clinical trials drag out. If we are lucky, Ancestry will help create some short-cuts for this whole process. Is that asking too much?

Thanks for the link.

[BBBabe]

Mingwan, Work2play, Arch, Bag8ger and all you guys....sometimes, when it is quietest with a company...that is the most important time and the most fruitful. Yes, the price drifts down for a while ~ but that's just part of the landscape with otcbb's. And one of the most important assets a company can have ~ is people like you guys, who do not cave in such times and whocontinue to connect the dots that the company is not allowed to do, at this time. I can only imagine how Tony must feel, at times.He is working very hard to make it happen for everyone concerned and because he doesn't have anything firm as yet, anything ripe for reporting, at the moment, he has to remain silent and in so doing, leaves a vacuum for naysayers, even liars to fill ~ in the discussion of DNAP and its future.I'm glad that there are investors here that keep on top of things and who, in so doing, encourage others who might believe the negative posts on R.B...Actually, I feel that this silence may prove to be 'golden'...as the saying goes...and that, in the months and years to come, we will look back on this period and realize that it was a positive, not a negative, for all, concerned.Companies that put out PR's about everything but what really matters are much more wearing than one that doesn't talk, until there is something very important to say. I could be wrong...but it's just how I still feel about DNAP...the ups and downs don't change my mind in the least.But reading you guys....is and always will be educational and enjoyable.GLTA... Babe